Dr. Bowlin has had a distinguished career encompassing over thirty years of anti-infective research, development, and management experience with pharmaceutical and biotechnology companies. Dr. Bowlin has extensive experience in drug discovery and development. Previously, Dr. Bowlin held the positions of Vice President, Research, at BioChem Pharma, and Director of Immunology at Marion Merrell Dow. Dr. Bowlin’s postdoctoral research was done at National Institutes of Health, and predoctoral research at the Cleveland Clinic. Dr. Bowlin holds a PhD in Cell Biology/Immunology from Cleveland State University.